Clinical Evidence for Durable Treatment of nAMD
Sabin Dang, MD
Jayanth Sridhar, MD
Clinical Evidence for Durable Treatment of DME
Christina Y. Weng, MD, MBA
Durga Borkar, MD, MMCi
Real-World Treatment of Retinal Disease
A Look at the Numbers: Cost of Durable Treatments in Retinal Disease
Real-World Outcomes with Durable Treatments for Retinal Diseases
Reconsidering the Algorithm: Treatment-Resistant DME
Reducing Retina Treatment Burden in the Real World: Emerging Evidence with Treatment Advances
Reconsidering the Algorithm: nAMD
Reconsidering the Algorithm: DME
Lessening Glaucoma Treatment Burden with Topical Therapies: The Evidence (Part 2)
Qi Cui, MD, PhD
Emerging Viewpoints on Diabetic Eye Health Disparities
Charles P. Vega, MD
Pradeep S. Prasad, MD, MBA
Ruth Shoge, OD, MPH, FAAO
Sharon D. Solomon, MD
Advances in Glaucoma Treatment: Individualizing Therapy to Improve Adherence
Davinder S. Grover, MD, MPH
Lessening Glaucoma Treatment Burden: Clinical Cases (Part 2)
Overcoming Barriers for Vulnerable Patients with Diabetic Eye Disease
Loading...
Stay current with the best on medical education
We’re glad to see you’re enjoying Eye Health Academy…but how about a more personalized experience?
Press cancel to remain on Eye Health Academy. Press the link below or the continue button to keep going.